The legacy of Viagra, and its developer copyright, presents a challenging case study for investors. Originally a blockbuster drug, generating billions in sales , its exclusivity period created a deluge of knock-off medications, significantly eroding its market share . While specific businesses may attempt to capitalize on similar conditions , the e